IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
2.300
+0.010 (0.44%)
At close: Aug 28, 2026, 4:00 PM EDT
2.210
-0.090 (-3.91%)
After-hours: Aug 28, 2026, 7:44 PM EDT
IceCure Medical Stock Forecast
ICCM's stock price has decreased by -92.22% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, IceCure Medical stock has a consensus rating of "Strong Buy" and an average price target of $22.67. The average 1-year stock price forecast is 885.65% higher than the current stock price, while the lowest is $10 (+334.78%) and the highest is $30 (+1,204.35%).
Price Target: $22.67 (+885.65%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for IceCure Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $30 → $10 | Buy | Maintains | $30 → $10 | +334.78% | Aug 14, 2026 |
| Brookline Capital Markets | Brookline Capital Markets | Buy Maintains $74 | Buy | Maintains | $74 | +3,095.65% | Jun 17, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $30 | Buy | Maintains | $30 | +1,204.35% | May 13, 2026 |
Financial Forecast
Revenue This Year
4.53M
from 3.38M
Increased by 34.08%
Revenue Next Year
8.80M
from 4.53M
Increased by 94.31%
EPS This Year
-4.61
from -7.20
EPS Next Year
-3.31
from -4.61
EPS and Forward PE are based on non-GAAP adjusted numbers.